ProPhase Labs Shares Outstanding 2006-2019 | PRPH

ProPhase Labs shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
ProPhase Labs Annual Shares Outstanding
(Millions of Shares)
2018 11
2017 16
2016 17
2015 16
2014 17
2013 16
2012 15
2011 15
2010 14
2009 13
2008 13
2007 13
2006 12
2005 13
ProPhase Labs Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 12
Q2 2019 12
Q1 2019 12
Q4 2018 11
Q3 2018 12
Q2 2018 11
Q1 2018 11
Q4 2017 16
Q3 2017 16
Q2 2017 17
Q1 2017 18
Q4 2016 17
Q3 2016 18
Q2 2016 17
Q1 2016 17
Q4 2015 16
Q3 2015 17
Q2 2015 16
Q1 2015 16
Q4 2014 17
Q3 2014 18
Q2 2014 17
Q1 2014 16
Q4 2013 16
Q3 2013 16
Q2 2013 16
Q1 2013 16
Q4 2012 15
Q3 2012 15
Q2 2012 15
Q1 2012 15
Q4 2011 15
Q3 2011 15
Q2 2011 15
Q1 2011 15
Q4 2010 14
Q3 2010 15
Q2 2010 15
Q1 2010 13
Q4 2009 13
Q3 2009 13
Q2 2009 13
Q1 2009 13
Q4 2008 13
Q3 2008 13
Q2 2008 13
Q1 2008 13
Q4 2007 13
Q3 2007 13
Q2 2007 13
Q1 2007 13
Q4 2006 13
Q3 2006 13
Q2 2006 12
Q1 2006 12
Q4 2005 13
Q3 2005 13
Q2 2005 12
Q1 2005 12
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.020B $0.013B
ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals that offer pioneering new options to improve patient treatment results. Its consumer health products, marketed through ProPhase Labs and certain subsidiaries, include the original COLD-EEZE?, a zinc gluconate glycine product. COLD-EEZE? family of lozenges and sugar free tablets reduce the severity and duration of the common cold. Its customers include wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs is also engaged in the research and development of potential natural base health products along with supplements and cosmeceuticals for human and veterinary use. The Company is headquartered in Doylestown, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.726B 38.02
Takeda Pharmaceutical (TAK) Japan $56.981B 10.10
Astellas Pharma (ALPMY) Japan $30.920B 15.44
Eisai (ESALY) Japan $22.211B 42.82
UCB SA (UCBJF) Belgium $18.867B 0.00
Grifols, S.A (GRFS) Spain $17.010B 22.29
Merck (MKGAF) Germany $16.730B 22.83
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Neurocrine Biosciences (NBIX) United States $8.946B 248.54
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Catalent (CTLT) United States $8.188B 33.69
Ionis Pharmaceuticals (IONS) United States $8.032B 16.27
Jazz Pharmaceuticals (JAZZ) Ireland $7.403B 9.46
IPSEN SA ADR (IPSEY) France $5.891B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.877B 0.00
Orion OYJ (ORINY) Finland $5.871B 30.12
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hypermarcas (HYPMY) Brazil $5.368B 16.33
United Therapeutics (UTHR) United States $5.062B 0.00
Nektar Therapeutics (NKTR) United States $3.934B 0.00
FibroGen (FGEN) United States $3.803B 111.77
Evotec AG (EVTCY) Germany $3.797B 61.27
Arrowhead Pharmaceuticals (ARWR) United States $3.699B 68.66
Sage Therapeutics (SAGE) United States $3.479B 0.00
PTC Therapeutics (PTCT) United States $3.383B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.822B 11.42
ChemoCentryx (CCXI) United States $2.728B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.153B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.983B 54.23
Xencor (XNCR) United States $1.890B 77.49
Heron Therapeutics (HRTX) United States $1.885B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.784B 21.68
Tilray (TLRY) Canada $1.738B 0.00
Corcept Therapeutics (CORT) United States $1.519B 17.04
USANA Health Sciences (USNA) United States $1.456B 15.22
CLINIGEN GP (CLIGF) United Kingdom $1.392B 0.00
Endo (ENDP) Ireland $1.361B 2.50
Theravance Biopharma (TBPH) Cayman Islands $1.334B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.328B 9.06
Zogenix (ZGNX) United States $1.279B 0.00
Akebia Therapeutics (AKBA) United States $1.188B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.025B 31.75
Portola Pharmaceuticals (PTLA) United States $1.016B 0.00
Aerie Pharmaceuticals (AERI) United States $0.940B 0.00
Karyopharm Therapeutics (KPTI) United States $0.929B 0.00
Radius Health (RDUS) United States $0.881B 0.00
Collegium Pharmaceutical (COLL) United States $0.796B 0.00
ImmunoGen (IMGN) United States $0.762B 0.00
Molecular Templates (MTEM) United States $0.633B 0.00
Flexion Therapeutics (FLXN) United States $0.620B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.548B 0.00
TherapeuticsMD (TXMD) United States $0.515B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.506B 61.38
Ardelyx (ARDX) United States $0.501B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.450B 19.40
Innate Pharma SA (IPHYF) France $0.446B 0.00
Translate Bio (TBIO) United States $0.441B 0.00
Organogenesis Holdings (ORGO) United States $0.424B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.407B 0.00
Calithera Biosciences (CALA) United States $0.404B 0.00
DURECT (DRRX) United States $0.402B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.398B 0.00
Lannett Co Inc (LCI) United States $0.378B 6.08
Siga Technologies (SIGA) United States $0.371B 8.46
Rigel Pharmaceuticals (RIGL) United States $0.369B 0.00
Harpoon Therapeutics (HARP) United States $0.362B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.357B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.356B 0.00
Recro Pharma (REPH) United States $0.355B 0.00
Indivior (INVVY) United States $0.353B 2.10
Rafael Holdings (RFL) United States $0.323B 0.00
Concert Pharmaceuticals (CNCE) United States $0.321B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.316B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.309B 0.00
OptiNose (OPTN) United States $0.288B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.248B 0.00
Ocular Therapeutix (OCUL) United States $0.247B 0.00
IMV INC (IMV) Canada $0.242B 0.00
MEI Pharma (MEIP) United States $0.242B 0.00
KalVista Pharmaceuticals (KALV) United States $0.237B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.196B 0.00
Nature's Sunshine Products (NATR) United States $0.194B 33.47
Taiwan Liposome (TLC) Taiwan $0.194B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.194B 0.00
Jounce Therapeutics (JNCE) United States $0.191B 2.56
Galmed Pharmaceuticals (GLMD) Israel $0.126B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.122B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.118B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.114B 0.00
CannTrust Holdings (CTST) Canada $0.113B 0.00
Xeris Pharmaceuticals (XERS) United States $0.111B 0.00
Otonomy (OTIC) United States $0.106B 0.00
Redhill Biopharma (RDHL) Israel $0.103B 0.00
Aquestive Therapeutics (AQST) United States $0.102B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.094B 0.00
CV Sciences (CVSI) United States $0.080B 0.00
Champions Oncology (CSBR) United States $0.080B 0.00
MediWound (MDWD) Israel $0.079B 0.00
Neos Therapeutics (NEOS) United States $0.078B 0.00
Infinity Pharmaceuticals (INFI) United States $0.076B 0.00
Onconova Therapeutics (ONTX) United States $0.072B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.067B 20.05
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
CTI BioPharma (CTIC) United States $0.063B 0.00
Nivalis Therapeutics (ALPN) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.061B 0.00
VAXART, INC (VXRT) United States $0.061B 0.00
Aclaris Therapeutics (ACRS) United States $0.059B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
IsoRay (ISR) United States $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Natural Alternatives (NAII) United States $0.050B 22.81
AgeX Therapeutics (AGE) United States $0.047B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.046B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.043B 0.00
PolarityTE (PTE) United States $0.042B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Jaguar Animal Health (JAGX) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.030B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.028B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
Vical (BBI) United States $0.027B 0.00
Cardiome Pharma (CORV) Canada $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.026B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Shineco (TYHT) China $0.017B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
Novan (NOVN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Hemispherx BioPharma (AIM) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.002B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00